May. 13 at 7:11 AM
$SGMO
That could happen, it always has in the past, and we know that. But that's unlikely to be an option right now.
Unlike 90% of other biotech companies in a similar situation, SGMO presents truly valuable goods and finished products that are generating significant interest. I wouldn't be surprised if there are currently extensive discussions taking place behind the scenes.
For this reason, I'm hoping for the following scenario:
Ladies and gentlemen, I know we've tested your patience considerably in the past, but we're all the more pleased to present the following partner to you today…